Pressreleases

Gerresheimer and Stevanato Group Announce Collaboration on the Development of an Innovative Ready-to-Use Vial Platform for the Pharmaceutical Industry

Gerresheimer and Stevanato Group announce that they have jointly developed a high-end ready-to-use (RTU) solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill® technology.

In Autumn 2022, CBDepot Returns to Live Pharma Shows

The Pharmacy Show in Birmingham, UK, starts on 16 October; our stand number is B02.
The biggest global pharmaceutical show, CPHI, is held in Frankfurt from 1 November; our stand nr. is 110F46.

Gerresheimer at Connect In Pharma: Safely Package and Administer Biotech and Pharmaceutical Products

At the premiere of Connect In Pharma, which takes place on 14 and 15 September in Geneva (Palexpo), Gerresheimer presents itself at booth A20. Gerresheimer is one of the founding partners of Connect in Pharma and will present its latest product solutions in the field of medical devices and packaging. A specialist lecture and a workshop will accompany the trade fair presentation.

LTS Takes Next Step in its Growth Journey with the Acquisition of Tapemark

LTS LOHMANN Therapie-Systeme (LTS) announces the closing of the acquisition of Tapemark, located in St Paul, Minnesota, USA. This acquisition combines Tapemark, a world-class CDMO specialised in transdermal drug delivery systems and oral thin film as well as unit dose semi-solid drug and iontophoresis products, with LTS, a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as transdermal patches (TTS), oral thin films (OTF) and micro array patches (MAP) for major bio/pharmaceutical, generic and consumer health companies.

Enabling the Next Wave of Innovative Drug Therapies with Speciality Enzymes

Approximately 75,000 enzymes are thought to exist in the human body as vital catalysts for biochemical reactions or conversions. For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. The pharmaceutical industry often relies on enzymes to perform a process known as biocatalysis, which facilitates the cost-effective and sustainable production of small molecule drugs at scale.

Gerresheimer Invests Up to $9.4m in US Production Facility

Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, today announced investments to rapidly expand its manufacturing, supply and logistics capability for glass vials in the US.

LTS Invests More Than €3m in Environmental Protection at the Andernach Site

LTS Lohmann Therapie-Systeme (LTS), market leader in the development and production of transdermal therapeutic systems and oral thin films, has invested €3m in a new regenerative thermal oxidiser (RTO) at its site in Andernach.

Technology cooperation between the University of Luxembourg and metrology specialist Anton Paar: Researchers sell first patent

Physicists at the University of Luxembourg have developed a novel optical measuring procedure, which will now be employed by a German company. This is the first patent resulting from research work that the University has ever sold.

Tosoh to Increase Production Capacity of Separation and Purification Media

Tosoh Corporation has announced it will increase the production capacity of separation and purification media TOYOPEARL®and TSKgel® PW at its Nanyo Complex (Shunan City, Yamaguchi Prefecture) in response to the growing demand for antibody and oligonucleotide drug purification.